title: Neuropeptide W has cell phenotype-specific effects on the excitability of different subpopulations of paraventricular nucleus neurones.
abstract: The administration of the neuropeptide W (NPW) and neuropeptide B (NPB) in rodents has been shown to influence the activity of a variety of autonomic and neuroendocrine systems. The paraventricular nucleus (PVN) is a major autonomic and neuroendocrine integration site in the hypothalamus, and neurones within this nucleus express the receptor for these ligands, NPB/W receptor 1 (NPBWR1). In the present study, we used whole cell patch clamp recordings coupled with single-cell reverse transcriptase-polymerase chain reaction to examine the effects of neuropeptide W-23 (NPW-23) on the excitability of identified PVN neurones. Oxytocin, vasopressin and thyrotrophin-releasing hormone neurones were all found to be responsive to 10 nm NPW-23, although both depolarising and hyperpolarising effects were observed in each of these cell groups. By contrast, corticotrophin-releasing hormone cells were unaffected. Further subdivision of chemically phenotyped cell groups into magnocellular, neuroendocrine or pre-autonomic neurones, using their electrophysiological fingerprints, revealed that neurones projecting to medullary and spinal targets were predominantly inhibited by NPW-23, whereas those that projected to median eminence or neural lobe showed almost equivalent numbers of depolarising and hyperpolarising cells. The demonstration of particular phenotypic populations of PVN neurones showing NPW-induced effects on excitability reinforces the importance of the NPB/NPW neuropeptide system as a regulator of autonomic function.
authors.affiliation: Department of Physiology, Queen's University, Kingston, Ontario, Canada.
authors.forename: C J
authors.initials: CJ
authors.lastname: Price
authors.forename: W K
authors.initials: WK
authors.lastname: Samson
authors.forename: A V
authors.initials: AV
authors.lastname: Ferguson
mesh_terms: D000200:Action Potentials; D000818:Animals; D003346:Corticotropin-Releasing Hormone / Q000378:metabolism; D008297:Male; D008473:Median Eminence / Q000502:physiology; D008526:Medulla Oblongata / Q000502:physiology; D008564:Membrane Potentials / Q000502:physiology; D009433:Neural Inhibition / Q000502:physiology; D009434:Neural Pathways / Q000502:physiology; D009474:Neurons / Q000502:physiology*; D009479:Neuropeptides / Q000378:metabolism*; D010121:Oxytocin / Q000378:metabolism; D010286:Paraventricular Hypothalamic Nucleus / Q000502:physiology*; D012333:RNA, Messenger / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley; D013116:Spinal Cord / Q000502:physiology; D013973:Thyrotropin-Releasing Hormone / Q000378:metabolism; D014667:Vasopressins / Q000378:metabolism
chemical_list: D009479:Neuropeptides; D012333:RNA, Messenger; C496874:neuropeptide W, rat; D014667:Vasopressins; D010121:Oxytocin; D013973:Thyrotropin-Releasing Hormone; D003346:Corticotropin-Releasing Hormone
references.citation: Brain Res. 2004 Aug 13;1017(1-2):222-6
references.pmid: 15261118
references.citation: Neuroendocrinology. 2008;88(2):88-94
references.pmid: 18285680
references.citation: J Physiol. 2000 Feb 15;523 Pt 1:193-209
references.pmid: 10673555
references.citation: J Endocrinol. 2006 Aug;190(2):213-23
references.pmid: 16899556
references.citation: Physiol Rev. 2000 Oct;80(4):1523-631
references.pmid: 11015620
references.citation: Neurosci Lett. 2007 Jan 3;411(1):67-71
references.pmid: 17067739
references.citation: Nature. 2000 Apr 6;404(6778):661-71
references.pmid: 10766253
references.citation: Endocrinology. 1999 Oct;140(10):4677-82
references.pmid: 10499525
references.citation: J Neuroendocrinol. 2002 Dec;14(12):929-32
references.pmid: 12472873
references.citation: Trends Neurosci. 1999 Feb;22(2):62-7
references.pmid: 10092045
references.citation: J Comp Neurol. 1980 Dec 1;194(3):555-70
references.pmid: 7451682
references.citation: Br J Pharmacol. 2006 Aug;148(8):1033-41
references.pmid: 16847439
references.citation: J Physiol. 2007 Dec 15;585(Pt 3):805-16
references.pmid: 17947308
references.citation: Am J Physiol Regul Integr Comp Physiol. 2004 Jul;287(1):R87-96
references.pmid: 15044184
references.citation: Endocrinology. 2009 Feb;150(2):832-40
references.pmid: 18948398
references.citation: J Neuroendocrinol. 2004 Oct;16(10):842-9
references.pmid: 15500544
references.citation: Am J Physiol Regul Integr Comp Physiol. 2005 Jun;288(6):R1727-32
references.pmid: 15886360
references.citation: Regul Pept. 2007 Feb 1;138(2-3):82-6
references.pmid: 17011641
references.citation: Thyroid. 1998 Oct;8(10):887-94
references.pmid: 9827655
references.citation: Endocrinology. 2003 Jul;144(7):2816-21
references.pmid: 12810535
references.citation: J Biol Chem. 2002 Sep 27;277(39):35826-32
references.pmid: 12130646
references.citation: J Comp Neurol. 2006 Jul 20;497(3):367-83
references.pmid: 16736466
references.citation: Results Probl Cell Differ. 2008;46:239-56
references.pmid: 18204824
references.citation: Proc Natl Acad Sci U S A. 2003 May 13;100(10):6251-6
references.pmid: 12719537
references.citation: Endocrinology. 2003 Nov;144(11):4729-33
references.pmid: 12959997
references.citation: Am J Physiol Regul Integr Comp Physiol. 2005 Jan;288(1):R270-5
references.pmid: 15345475